Author:
Liang D-C,Chang T-T,Lin K-H,Lin D-T,Lu M-Y,Chen S-H,Liu H-C,Lin M-T,Lee M-T,Shu S-G,Chang T-K,Chen J-S,Hsiao C-C,Hung I-J,Hsieh Y-L,Chen R-L,Cheng S-N,Chang W-H,Lee C-H,Lin K-S
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference59 articles.
1. Estey EH, Keating MJ, McCredie KB, Bodey GP, Freireich EJ . Phase II trial of mitoxantrone in refractory acute leukemia. Cancer Treat Rep 1983; 67: 389–390.
2. Bishop JF, Lowenthal RM, Joshua D, Matthews JP, Todd D, Cobcroft R, et al., for the Australian Leukemia Study Group. Etoposide in acute nonlymphocytic leukemia: Australian Leukemia Study Group. Blood 1990; 75: 27–32.
3. Büchner T, Hiddemann W, Löffler G, Gassmann W, Maschmeyer G, Heit W et al. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group. Semin Hematol 1991; 28: 76–79.
4. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 1994; 331: 896–903.
5. Wells RJ, Woods WG, Lampkin BC, Nesbit ME, Lee JW, Buckley JD et al. Impact of high-dose cytarabine and asparaginase intensification on childhood acute myeloid leukemia: a report from the Childrens Cancer Group. J Clin Oncol 1993; 11: 538–545.
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献